Acute Pneumonia in Young Children

Acute pneumonia remains one of the most prevalent and life-threatening infectious diseases in children under the age of five, particularly in low- and middle-income countries. Despite significant advances in preventive and therapeutic interventions, it continues to account for a substantial portion of global childhood morbidity and mortality. The World Health Organization reports that pneumonia is responsible for approximately 15% of all deaths in children under five years of age, equating to more than 800,000 deaths annually. The disease is characterized by inflammation of the lung parenchyma, often resulting from infections with viral, bacterial, or less commonly fungal pathogens. The clinical presentation of acute pneumonia in young children is highly variable, ranging from mild respiratory symptoms to severe respiratory distress requiring hospitalization and intensive care. The etiological landscape of pediatric pneumonia is shaped by the child’s age, immunization status, geographic region, and underlying health conditions. Respiratory syncytial virus (RSV) is the most common viral pathogen, especially in infants and toddlers, while Streptococcus pneumoniae and Haemophilus influenzae type b remain leading bacterial agents despite widespread immunization programs. Accurate and timely diagnosis is paramount and is primarily based on clinical signs such as tachypnea, cough, fever, and chest indrawing. The WHO has developed age-specific criteria for identifying pneumonia in children, which aid healthcare providers, especially in resource-limited settings, where access to advanced diagnostic tools may be restricted. Management strategies differ based on the severity of the illness. Non-severe cases are usually managed at home with oral antibiotics such as amoxicillin, while severe or complicated cases necessitate hospital admission for intravenous antibiotics, oxygen therapy, and supportive care. Prevention strategies, including immunization against pneumococcus, Hib, and influenza, exclusive breastfeeding, improved nutrition, and reduction of indoor air pollution, have shown substantial success in decreasing pneumonia incidence and mortality. This article aims to provide a comprehensive review of the current understanding of acute pneumonia in young children. It explores the disease's etiology, pathophysiology, clinical manifestations, diagnostic criteria, differential diagnoses, treatment modalities, complications, and preventive measures. By synthesizing current evidence and international guidelines, the article underscores the importance of early recognition and holistic management of pneumonia in pediatric populations to improve health outcomes and reduce the global disease burden.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-24
DOI
https://doi.org/10.5281/zenodo.15274982
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Acute Pneumonia in Young Children

Zenodo (CERN European Organization for Nuclear Research)
Respiratory viral infections research
article

Acute Pneumonia in Young Children

article en

Abstract

Acute pneumonia remains one of the most prevalent and life-threatening infectious diseases in children under the age of five, particularly in low- and middle-income countries. Despite significant advances in preventive and therapeutic interventions, it continues to account for a substantial portion of global childhood morbidity and mortality. The World Health Organization reports that pneumonia is responsible for approximately 15% of all deaths in children under five years of age, equating to more than 800,000 deaths annually. The disease is characterized by inflammation of the lung parenchyma, often resulting from infections with viral, bacterial, or less commonly fungal pathogens. The clinical presentation of acute pneumonia in young children is highly variable, ranging from mild respiratory symptoms to severe respiratory distress requiring hospitalization and intensive care. The etiological landscape of pediatric pneumonia is shaped by the child’s age, immunization status, geographic region, and underlying health conditions. Respiratory syncytial virus (RSV) is the most common viral pathogen, especially in infants and toddlers, while Streptococcus pneumoniae and Haemophilus influenzae type b remain leading bacterial agents despite widespread immunization programs. Accurate and timely diagnosis is paramount and is primarily based on clinical signs such as tachypnea, cough, fever, and chest indrawing. The WHO has developed age-specific criteria for identifying pneumonia in children, which aid healthcare providers, especially in resource-limited settings, where access to advanced diagnostic tools may be restricted. Management strategies differ based on the severity of the illness. Non-severe cases are usually managed at home with oral antibiotics such as amoxicillin, while severe or complicated cases necessitate hospital admission for intravenous antibiotics, oxygen therapy, and supportive care. Prevention strategies, including immunization against pneumococcus, Hib, and influenza, exclusive breastfeeding, improved nutrition, and reduction of indoor air pollution, have shown substantial success in decreasing pneumonia incidence and mortality. This article aims to provide a comprehensive review of the current understanding of acute pneumonia in young children. It explores the disease's etiology, pathophysiology, clinical manifestations, diagnostic criteria, differential diagnoses, treatment modalities, complications, and preventive measures. By synthesizing current evidence and international guidelines, the article underscores the importance of early recognition and holistic management of pneumonia in pediatric populations to improve health outcomes and reduce the global disease burden.

Zenodo (CERN European Organization for Nuclear Research)
Osh State University (KG)
Openalex Percentile: Top 44%
Respiratory viral infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.